News
They're fueling the war machine, and if they're going to do that, then I'm not going to be happy,” Donald Trump told CNBC in ...
The projects — 22 of them — are being led by some of the nation’s leading pharmaceutical companies like Pfizer and Moderna to ...
U.S. President Donald Trump raised the tariffs on Canadian goods to 35% last week, but a key exemption for Canada and Mexico ...
In a wide-ranging interview on CNBC, the President said he could raise his looming 25% tariff on India even higher because of ...
The Trump administration says it's aiming to lower drug costs for Americans. It's given drug companies 60 days to lower ...
President Donald Trump provided new details about his plan to impose tariffs on foreign-made pharmaceuticals, but the White ...
All told, the S&P 500 rose 91.93 points to 6,329.94. The Dow Jones Industrial Average climbed 585.06 to 44,173.64, and the ...
CNBC's Jim Cramer on Tuesday pushed back against a downbeat sentiment he's felt on Wall Street, saying "kneejerk negativity" is making investors lose money.
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
On a gut level, it's still hard to believe that investors have fully priced in the whole "the US is run by an actual mad man" ...
Dozens of companies are reporting lower profits caused by Trump's tariffs. Stock values haven't adjusted — yet.
The Brazilian Supreme Court justice’s order could complicate efforts to negotiate over President Trump’s punishing tariffs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results